tirzepatide device FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Demonstrates 94% Diabetes Reduction,

Several estimates peggs the generic competition to bring a major price relief for patients, with the drug monthly dosage cost will go as low as up to Rs 4,000 down from the current range of Rs 14,000-Rs 25,000 depending on the brand.

GLP-1 therapy can be one part of a broader weight-management conversation when a provider determines medication support is clinically appropriate

NAC gummies: N-acetyl cysteine, the key ingredient in NAC supplement gummies, helps support the body's production of glutathione

Efficacy and safety of coenzyme q10 supplementation in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis